Colorectal Cancer Clinical Trials in San Diego

Showing 81-100 of 123 trials

Minimally Invasive Surgery (MIS) Database for the Purpose of Research

NCT00535990

The Minimally Invasive Surgery Team (MIST) are establishing a separate research database to find out more about patient's undergoing minimally invasive surgery (laparoscopic , open and robot assisted) procedures at UCSD. The hope is that collection of this information will give physicians a better knowledge and understanding of the benefits of minimally invasive surgery and possibly assist physicians to better manage future patients.

Morbid ObesityHerniaColorectal Cancer+1 more

University of California, San Diego250 participantsStarted Sep 2007

San Diego, California, United States

COMPLETEDPHASE2< 1 mile

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

NCT02083653

This is a Phase 2, open-label, randomized, 3-arm trial investigating the efficacy of two Sym004 doses (Arm A and Arm B) compared with a control group (Arm C) in subjects with metastatic colorectal cancer (mCRC) and acquired resistance to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs).

Metastatic Colorectal Cancer

Symphogen A/S254 participantsStarted Mar 2014

Los Angeles, California, United States • San Diego, California, United States • Fort Myers, Florida, United States +51 more locations

Minimally Invasive Surgery (MIS) Database for the Purpose of Research

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

RObotic Versus LAparoscopic Resection for Rectal Cancer

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

Other Conditions in San Diego